Abeona therapeutics announces clinical investigator webinar to review abo-102 and abo-101 clinical data presented at the 17th annual worldsymposium™

New york and cleveland, feb. 02, 2021 (globe newswire) -- abeona therapeutics inc. (nasdaq: abeo), a fully-integrated leader in gene and cell therapy, today announced that it will host a live webinar for the investment community on tuesday, february 16, 2021 at 1:00 p.m. est to review clinical data on the company's investigational aav-based gene therapies abo-102 and abo-101 presented at the 17th annual worldsymposium™.
ABEO Ratings Summary
ABEO Quant Ranking